tradingkey.logo
tradingkey.logo
Buscar

Enovis Corp

ENOV
Añadir a la lista de seguimiento
21.700USD
+1.660+8.28%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
1.25BCap. mercado
PérdidaP/E TTM

Más Datos de Enovis Corp Compañía

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Información de Enovis Corp

Símbolo de cotizaciónENOV
Nombre de la empresaEnovis Corp
Fecha de salida a bolsaMay 08, 2008
Director ejecutivoMcdonald (Damien)
Número de empleados7367
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 08
Dirección2711 Centerville Road
CiudadWILMINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal19808
Teléfono13022529160
Sitio Webhttps://www.enovis.com/
Símbolo de cotizaciónENOV
Fecha de salida a bolsaMay 08, 2008
Director ejecutivoMcdonald (Damien)

Ejecutivos de Enovis Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
18.37K
+50.87%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
17.60K
+53.09%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
18.37K
+50.87%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Enovis Corp?

Los cinco principales accionistas de Enovis Corp son: Mr. Daniel Alexis Pryor

¿Cuántas instituciones poseen acciones de Enovis Corp (ENOV)?

A fecha de 2026Q1, 652 instituciones poseen acciones de Enovis Corp, con un valor de mercado combinado de aproximadamente 68.97M, lo que representa el 119.81% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -6763998.00.

¿Cuál es la mayor fuente de ganancias de Enovis Corp?

El 2026Q1, el segmento empresarial Medical Technology-Prevention & Rehabilitation generó la ganancia más alta para Enovis Corp, ascendiendo a 1.14B y representando el 50.58% de la ganancia total.